Literature DB >> 23553486

MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a.

Simona Giglio1, Roberto Cirombella, Rachele Amodeo, Luciano Portaro, Luca Lavra, Andrea Vecchione.   

Abstract

Cell cycle progression is controlled by numerous mechanisms ensuring correct cell division. The transition from one cell cycle phase to another occurs in an orderly fashion and is regulated by different cellular proteins. Therefore an alteration of the regulatory mechanisms of the cell cycle results in uncontrolled cell proliferation, which is a distinctive feature of human cancers. Recent evidences suggest that microRNAs (miRs) may also control the levels of multiple cell cycle regulators and therefore control cell proliferation. In fact miRs are a class of small non-coding RNAs, which modulate gene expression. They are involved in numerous physiological cellular processes and most importantly accumulating evidence indicates that many miRs are aberrantly expressed in human cancers. In this report we describe that miR-24 directly targets p27(Kip1) and p16(Ink4a) in primary keratinocyte and in different cancer derived cell lines promoting their proliferation, suggesting that miR-24 is involved in cyclin-dependent kinase inhibitors post-transcriptional regulation and that upregulation of miR-24 may play a role in carcinogenesis.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553486     DOI: 10.1002/jcp.24368

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

1.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

Review 2.  Not miR-ly micromanagers: the functions and regulatory networks of microRNAs in mammalian skin.

Authors:  Kent Riemondy; Jaimee E Hoefert; Rui Yi
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-07-09       Impact factor: 9.957

3.  MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.

Authors:  Vince Kornél Grolmusz; Katalin Borka; Annamária Kövesdi; Kinga Németh; Katalin Balogh; Csaba Dékány; András Kiss; Anna Szentpéteri; Beatrix Sármán; Anikó Somogyi; Éva Csajbók; Zsuzsanna Valkusz; Miklós Tóth; Péter Igaz; Károly Rácz; Attila Patócs
Journal:  Virchows Arch       Date:  2017-06-08       Impact factor: 4.064

4.  Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells.

Authors:  F Akbari Moqadam; J M Boer; E A M Lange-Turenhout; R Pieters; M L den Boer
Journal:  Leukemia       Date:  2013-10-23       Impact factor: 11.528

5.  miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes.

Authors:  Declan J McKenna; Daksha Patel; Dennis J McCance
Journal:  Virology       Date:  2013-10-29       Impact factor: 3.616

Review 6.  MicroRNA aberrations: An emerging field for gallbladder cancer management.

Authors:  Vishal Chandra; Jong Joo Kim; Balraj Mittal; Rajani Rai
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

7.  Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.

Authors:  Yang Gao; Yimin Liu; Lutao Du; Juan Li; Ailin Qu; Xin Zhang; Lili Wang; Chuanxin Wang
Journal:  Med Oncol       Date:  2014-12-13       Impact factor: 3.064

8.  miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.

Authors:  Ying Ma; Xing-guo She; Ying-zi Ming; Qi-quan Wan
Journal:  Tumour Biol       Date:  2014-07-30

Review 9.  The molecular balancing act of p16(INK4a) in cancer and aging.

Authors:  Kyle M LaPak; Christin E Burd
Journal:  Mol Cancer Res       Date:  2013-10-17       Impact factor: 5.852

10.  Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.

Authors:  Ling Mao; Jian Li; Wei-Xian Chen; Yan-Qin Cai; Dan-Dan Yu; Shan-Liang Zhong; Jian-Hua Zhao; Jian-Wei Zhou; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.